Cargando…

GH Replacement in the Elderly: Is It Worth It?

Growth hormone (GH), once the age of linear growth is completed, continues to play a fundamental role for the human body. In adulthood, GH contributes to regulate muscle, cardiovascular and bone metabolism. The same happens in old age, although there is less data on the effect of GH in the elderly....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricci Bitti, Silvia, Franco, Marta, Albertelli, Manuela, Gatto, Federico, Vera, Lara, Ferone, Diego, Boschetti, Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239420/ https://www.ncbi.nlm.nih.gov/pubmed/34211437 http://dx.doi.org/10.3389/fendo.2021.680579

Ejemplares similares

Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up
por: Franco, Marta, et al.
Publicado: (2023)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
por: Albertelli, Manuela, et al.
Publicado: (2023)

"Present and future of immunotherapy in Neuroendocrine Tumors"
por: Albertelli, Manuela, et al.
Publicado: (2021)

Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients
por: Nazzari, Elena, et al.
Publicado: (2022)

GH Deficiency and Replacement Therapy in Hypopituitarism: Insight Into the Relationships With Other Hypothalamic-Pituitary Axes
por: Profka, Eriselda, et al.
Publicado: (2021)

Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
por: Gatto, Federico, et al.
Publicado: (2019)

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
por: Stagi, Stefano, et al.
Publicado: (2022)

Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective
por: Nista, Federica, et al.
Publicado: (2021)

Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
por: Barbieri, Federica, et al.
Publicado: (2014)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica, Giuliana, et al.
Publicado: (2020)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

2-[(18)F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
por: Gay, Stefano, et al.
Publicado: (2022)

Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose
por: Marabotto, Elisa, et al.
Publicado: (2022)

Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
por: Patti, L., et al.
Publicado: (2023)

Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
por: Giuffrida, Giuseppe, et al.
Publicado: (2022)

Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

Sodium Intake and Target Organ Damage in Hypertension—An Update about the Role of a Real Villain
por: Nista, Federica, et al.
Publicado: (2020)

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)

Testicular Growth and Pubertal Onset in GH-Deficient Children Treated With Growth Hormone: A Retrospective Study
por: Cannarella, Rossella, et al.
Publicado: (2021)

Imatinib Inhibits GH Secretion From Somatotropinomas
por: Gupta, Prakamya, et al.
Publicado: (2018)

Is GH Replacement for Adult GH Deficiency Safe?
por: Melmed, Shlomo
Publicado: (2022)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

The crosstalk between FGF21 and GH leads to weakened GH receptor signaling and IGF1 expression and is associated with growth failure in very preterm infants
por: Mistry, Jayna N., et al.
Publicado: (2023)

Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests
por: Bioletto, Fabio, et al.
Publicado: (2021)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors
por: Re, Agnese, et al.
Publicado: (2020)

LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency
por: Bright, George, et al.
Publicado: (2021)

Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency
por: Ranke, Michael B.
Publicado: (2021)

GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer
por: Catellani, Cecilia, et al.
Publicado: (2021)

Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance
por: Cianfarani, Stefano
Publicado: (2021)

Increase of jump performance during GH treatment in short children born SGA
por: Schweizer, Roland, et al.
Publicado: (2023)

OR10-02 Diagnosis of Severe GH Deficiency in Newborns: New Reference Range for the Preterm and Confirmation of the GH Cut-Off
por: Binder, Gerhard, et al.
Publicado: (2020)

Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Cardinal, Tyler, et al.
Publicado: (2021)

GH treatment in pediatric Down syndrome: a systematic review and mini meta-analysis
por: Shaki, David, et al.
Publicado: (2023)

Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
por: Höybye, Charlotte, et al.
Publicado: (2014)

Specific miRNAs Change After 3 Months of GH treatment and Contribute to Explain the Growth Response After 12 Months
por: Catellani, Cecilia, et al.
Publicado: (2022)

A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
por: Chen, Zhiyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rttp8b7l7698m6j57gvf588sh3